Skip to main content
. Author manuscript; available in PMC: 2009 Feb 3.
Published in final edited form as: Eur J Heart Fail. 2008 Jan 30;10(2):133–139. doi: 10.1016/j.ejheart.2007.12.009

Table 2.

Stromelysin-1 (MMP-3) levels in relation to the occurrence of clinical endpoints.

Endpoint MMP-3 (pg/ml) median [range]
Event No event p-value
Death/heart failure (N=58)   9141.2 6230.2 0.001
Death (N=33) 9076.0 6550.1 0.033
Heart failure (N=46) 8068.0 6505.8 0.033
Reinfarction (N=42) 6941.6 6630.8 0.923